Consensus DR Horton

Stocks

DHI

US23331A1097

Homebuilding

Market Closed - NYSE 01:30:02 02/10/2026 am IST			5-day change	1st Jan Change
137.06 ^USD	+0.30%		-2.22%	-4.84%

03:40pm	Morgan Stanley Initiates D.R. Horton at Equalweight With $151 Price Target	MT
26/09	M&C Properties, LLC acquired Ascend at Black Canyon from D.R. Horton, Inc. for $58.7 million.	CI

Evolution of the Average Target: DR Horton

Evolution of the Target Price: DR Horton

Changes in Analyst Recommendations: DR Horton

9da71f16add96296b7.cdLlm5DeoPhN8IGPIakadh6BqkNnhJqyrMnbbmq7Kcs.HKOM4sa6lashkcDhVdBQOE2sySY066v62ZiWGDXRHqMugq_S4ovOiwfE1A~dedac1e3e95cb97ac34e0f6cde28baea

Analysts' recommendations: DR Horton

03:40pm	Morgan Stanley Initiates D.R. Horton at Equalweight With $151 Price Target	MT
25/09	Evercore ISI Adjusts Price Target on D.R. Horton to $166 From $177, Maintains In Line Rating	MT
22/09	Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $160 From $167, Keeps Market Perform Rating	MT
22/09	BTIG Adjusts Price Target on D.R. Horton to $174 From $184, Keeps Buy Rating	MT
21/09	Keefe, Bruyette & Woods Adjusts Price Target on D.R. Horton to $160 From $167	MT
18/09	Wall Street's Relief Has Limits
16/09	Meritage Homes Likely to Increase Homebuyer Incentives Amid High Mortgage Rates, Truist Says	MT
16/09	Truist Cuts Price Target on D.R. Horton to $140 From $150, Keeps Hold Rating	MT
11/09	Wells Fargo Adjusts Price Target on D.R. Horton to $145 From $155, Maintains Equalweight Rating	MT
04/08	Wells Fargo Adjusts Price Target on D.R. Horton to $155 From $170, Maintains Equalweight Rating	MT
22/07	Citigroup Adjusts Price Target on D.R. Horton to $160 From $173, Maintains Neutral Rating	MT
22/07	BTIG Adjusts Price Target on D.R. Horton to $184 From $188, Maintains Buy Rating	MT
22/07	RBC Lifts Price Target on D.R. Horton to $125 From $123, Keeps Underperform Rating	MT
22/07	Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $167 From $175, Maintains Market Perform Rating	MT
22/07	Goldman Sachs Adjusts Price Target on D.R. Horton to $190 From $186, Maintains Buy Rating	MT
22/07	Evercore ISI Adjusts Price Target on D.R. Horton to $177 From $171, Maintains In Line Rating	MT
14/07	Barclays Adjusts Price Target on D.R. Horton to $141 From $140, Maintains Equalweight Rating	MT
10/07	Goldman Sachs Adjusts Price Target on D.R. Horton to $186 From $190	MT
09/07	D.R. Horton Quarterly Earnings Poised for Beat Amid Multiple Tailwinds, Oppenheimer Says	MT
22/04	UBS Adjusts D.R. Horton Price Target to $206 From $193, Maintains Buy Rating	MT
22/04	Truist Raises Price Target on D.R. Horton to $150 From $140, Keeps Hold Rating	MT
22/04	Citigroup Adjusts Price Target on D.R. Horton to $173 From $162, Maintains Neutral Rating	MT
22/04	Keefe, Bruyette & Woods Adjusts Price Target on D.R. Horton to $175 From $163, Maintains Market Perform Rating	MT
22/04	Evercore ISI Adjusts Price Target on D.R. Horton to $171 From $153, Maintains In Line Rating	MT
22/04	Goldman Sachs Adjusts Price Target on D.R. Horton to $190 From $172, Maintains Buy Rating	MT

More recommendations

Other Homebuilding

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DR HORTON					+16.29%
	PULTEGROUP, INC.					+21.32%
	LENNAR CORPORATION					-1.85%
	DAIWA HOUSE INDUSTRY CO., LTD.					+15.41%
	NVR, INC.					+9.15%
	SEKISUI HOUSE, LTD.					+14.38%
	TOLL BROTHERS, INC.					+27.2%
	SEKISUI CHEMICAL CO., LTD.					+5.63%
	BARRATT REDROW PLC					+0.49%
	Average					+12.00%
	Weighted average by Cap.					+13.43%